EGFR and cancer: Other EGFR ligands that have a lower affinity to EGF, such as TGF-α, HB-EGF, AREG, BTC, and EPGN, may stimulate the growth, invasion, and metastasis due to their dysregulation in cancer, which promotes the higher tumor survival through autocrine or paracrine stimulation.